⌘K

Login Start Free

Home/Filings/5/0001387131-22-001714

5//SEC Filing

SULLIVAN GREGORY M 5

Accession 0001387131-22-001714

CIK 0001430306other

View on SEC.gov Company Profile

Filed

Feb 10, 7:00 PM ET

Accepted

Feb 11, 5:17 PM ET

Size

4.9 KB

Accession

0001387131-22-001714

Insider Transaction Report

Form 5

Period: 2021-12-31

Tonix Pharmaceuticals Holding Corp.TNXP

SULLIVAN GREGORY M

Chief Medical Officer

Transactions

Award
Common Stock, par value $0.001
2021-06-30$0.58/sh+36,496$21,168→ 99,223 total

Footnotes (1)

[F1]Shares acquired through the Tonix Pharmaceuticals Holding Corp. 2020 Employee Stock Purchase Plan.

Documents

1 file

5
ownership.xmlPrimary
BENEFICIAL OWNERSHIP

Issuer

Tonix Pharmaceuticals Holding Corp.

CIK 0001430306

Entity typeother

Related Parties

1

filerCIK 0001610106

Filing Metadata

Form type: 5
Filed: Feb 10, 7:00 PM ET
Accepted: Feb 11, 5:17 PM ET
Size: 4.9 KB

View on SEC.gov